A detailed history of King Wealth transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, King Wealth holds 13,700 shares of ALDX stock, worth $66,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,700
Previous 11,000 24.55%
Holding current value
$66,856
Previous $36,000 105.56%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$3.19 - $6.32 $8,613 - $17,064
2,700 Added 24.55%
13,700 $74,000
Q2 2024

Aug 08, 2024

BUY
$3.25 - $4.72 $3,250 - $4,720
1,000 Added 10.0%
11,000 $36,000
Q1 2024

May 09, 2024

BUY
$2.77 - $4.22 $27,700 - $42,200
10,000 New
10,000 $33,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $285M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track King Wealth Portfolio

Follow King Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.